{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:11Z","timestamp":1787908931290,"version":"build-2784847793"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074450"],"award-info":[{"award-number":["82074450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05622-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:25:24Z","timestamp":1783153524000},"page":"3715-3732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PER1 reduces HIF-1\u03b1 nuclear accumulation and modulates vascular remodeling in hepatocellular carcinoma"],"prefix":"10.1007","volume":"481","author":[{"given":"Zhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"5622_CR1","doi-asserted-by":"crossref","unstructured":"Li Q, Ding C, Cao M, Yang F, Yan X, He S, Cao M, Zhang S, Teng Y, Tan N, Wang J (2022) Global epidemiology of liver cancer 2022: an emphasis on geographic disparities. Chin Med J 137(19):2334\u201342","DOI":"10.1097\/CM9.0000000000003264"},{"key":"5622_CR2","doi-asserted-by":"crossref","unstructured":"Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VE, Soerjomataram I (2022) Global, regional andnational burden of primary liver cancer by subtype. Eur J Cancer 161:108\u2013118","DOI":"10.1016\/j.ejca.2021.11.023"},{"key":"5622_CR3","doi-asserted-by":"crossref","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, Bonaventure A, Valkov M, Johnson CJ, Est\u00e8ve J, Ogunbiyi OJ (2018) Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023\u20131075","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"5622_CR4","doi-asserted-by":"crossref","unstructured":"Tulessin M, Sarker RSJ, Griger J, Leibing T, Geraud C, Weichert W, Steiger K, Mogler C (2022) Vascular remodeling is a crucial event in the early phase of hepatocarcinogenesis in rodent models for liver tumorigenesis. Cells 11(14):2129","DOI":"10.3390\/cells11142129"},{"key":"5622_CR5","doi-asserted-by":"crossref","unstructured":"Yao C, Wu S, Kong J, Sun Y, Bai Y, Zhu R, Li Z, Sun W, Zheng L (2023) Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biol Med 20(1):25\u201343","DOI":"10.20892\/j.issn.2095-3941.2022.0449"},{"key":"5622_CR6","doi-asserted-by":"crossref","unstructured":"Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401\u2013410","DOI":"10.1038\/nrc1093"},{"key":"5622_CR7","doi-asserted-by":"crossref","unstructured":"Naumov GN, Akslen LA, Folkman J (2006) Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5(16):1779\u201387","DOI":"10.4161\/cc.5.16.3018"},{"key":"5622_CR8","doi-asserted-by":"crossref","unstructured":"Zhang Q, Wu J, Bai X, Liang T (2020) Evaluation of intra-tumoral vascularization in hepatocellular carcinomas. Front Med (Lausanne) 7:584250","DOI":"10.3389\/fmed.2020.584250"},{"key":"5622_CR9","doi-asserted-by":"crossref","unstructured":"Li X, Pan J, Liu T, Yin W, Miao Q, Zhao Z, Gao Y, Zheng W, Li H, Deng R, Huang D (2023) Novel TCF21high pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix. Gut 72(4):710\u201321","DOI":"10.1136\/gutjnl-2022-327913"},{"key":"5622_CR10","doi-asserted-by":"crossref","unstructured":"Mukwaya A, Jensen L, Lagali N (2021) Relapse of pathological angiogenesis: functional role of the basement membrane and potential treatment strategies. Exp Mol Med 53(2):189\u2013201","DOI":"10.1038\/s12276-021-00566-2"},{"key":"5622_CR11","doi-asserted-by":"crossref","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H (2025) Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther 10(1):35","DOI":"10.1038\/s41392-024-02075-w"},{"key":"5622_CR12","doi-asserted-by":"crossref","unstructured":"Choi Y, Jung K (2023) Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy. Exp Mol Med 55(11):2308\u201319","DOI":"10.1038\/s12276-023-01114-w"},{"key":"5622_CR13","doi-asserted-by":"crossref","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W (2023) Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8(1):70","DOI":"10.1038\/s41392-023-01332-8"},{"key":"5622_CR14","doi-asserted-by":"crossref","unstructured":"Meng YM, Jiang X, Zhao X, Meng Q, Wu S, Chen Y, Kong X, Qiu X, Su L, Huang C, Wang M, Liu C, Wong PP (2021) Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities. Nat Commun 12(1):6011","DOI":"10.1038\/s41467-021-26259-y"},{"key":"5622_CR15","doi-asserted-by":"crossref","unstructured":"Shen R, Peng L, Zhou W, Wang D, Jiang Q, Ji J, Hu F, Yuan H (2022) Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor. J Control Release 349:550\u2013564","DOI":"10.1016\/j.jconrel.2022.07.015"},{"key":"5622_CR16","doi-asserted-by":"crossref","unstructured":"Hedlund EM, Hosaka K, Zhong Z, Cao R, Cao Y (2009) Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature. Proc Natl Acad Sci U S A 106(41):17505\u201317510","DOI":"10.1073\/pnas.0908026106"},{"key":"5622_CR17","doi-asserted-by":"crossref","unstructured":"Eelen G, Treps L, Li X, Carmeliet P (2020) Basic and therapeutic aspects of angiogenesis updated. Circ Res 127(2):310\u201329","DOI":"10.1161\/CIRCRESAHA.120.316851"},{"key":"5622_CR18","doi-asserted-by":"crossref","unstructured":"Jayson GC, Kerbel R, Ellis LM, Harris AL (2016) Antiangiogenic therapy in oncology: current status and future directions. Lancet 388(10043):518\u2013529","DOI":"10.1016\/S0140-6736(15)01088-0"},{"key":"5622_CR19","doi-asserted-by":"crossref","unstructured":"Lee P, Chandel NS, Simon MC (2020) Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol 21(5):268\u2013283","DOI":"10.1038\/s41580-020-0227-y"},{"key":"5622_CR20","doi-asserted-by":"crossref","unstructured":"Huynh KN, Rao S, Roth B, Bryan T, Fernando DM, Dayyani F, Imagawa D, Abi-Jaoudeh N (2023) Targeting hypoxia-inducible factor-1\u03b1 for the management of hepatocellular carcinoma. Cancers (Basel) 15(10):2738","DOI":"10.3390\/cancers15102738"},{"key":"5622_CR21","doi-asserted-by":"crossref","unstructured":"Basu RK, Hubchak S, Hayashida T, Runyan CE, Schumacker PT, Schnaper HW (2011) Interdependence of HIF-1\u03b1 and TGF-\u03b2\/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol 300(4):F898-905","DOI":"10.1152\/ajprenal.00335.2010"},{"key":"5622_CR22","doi-asserted-by":"crossref","unstructured":"Conte C, Riant E, Toutain C, Pujol F, Arnal JF, Lenfant F, Prats AC (2008) FGF2 translationally induced by hypoxia is involved in negative and positive feedback loops with HIF-1\u03b1. PLoS One 3(8):e3078","DOI":"10.1371\/journal.pone.0003078"},{"key":"5622_CR23","doi-asserted-by":"crossref","unstructured":"Lungu CN, Gurau G, Mehedinti MC (2025) Pro-angiogenic bioactive molecules in vascular morphogenesis: integrating endothelial cell dynamics. Curr Issues Mol Biol 47(10):851","DOI":"10.3390\/cimb47100851"},{"key":"5622_CR24","doi-asserted-by":"crossref","unstructured":"Luo YW, Fang Y, Zeng HX, Ji YC, Wu MZ, Li H, Chen JY, Zheng LM, Fang JH, Zhuang SM (2025) HIF1\u03b1 counteracts TGF\u03b21-driven TSP1 expression in endothelial cells to stimulate angiogenesis in the hypoxic tumor microenvironment. Cancer Res 85(1):69\u201383","DOI":"10.1158\/0008-5472.CAN-24-2324"},{"key":"5622_CR25","doi-asserted-by":"crossref","unstructured":"Kai AK, Chan LK, Lo RC, Lee JM, Wong CC, Wong JC, Ng IO (2016) Down-regulation of TIMP2 by HIF\u20101\u03b1\/miR\u2010210\/HIF\u20103\u03b1 regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Hepatology 64(2):473\u201387","DOI":"10.1002\/hep.28577"},{"key":"5622_CR26","doi-asserted-by":"crossref","unstructured":"Lee Y (2021) Roles of circadian clocks in cancer pathogenesis and treatment. Exp Mol Med 53(10):1529\u201338","DOI":"10.1038\/s12276-021-00681-0"},{"key":"5622_CR27","doi-asserted-by":"crossref","unstructured":"Zhao B, Nepovimova E, Wu Q (2025) The role of circadian rhythm regulator PERs in oxidative stress, immunity, and cancer development. Cell Commun Signal 23(1):30","DOI":"10.1186\/s12964-025-02040-2"},{"key":"5622_CR28","doi-asserted-by":"crossref","unstructured":"Yang G, Yang Y, Tang H, Yang K (2020) Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT\/mTOR pathway. Cancer Sci 111(5):1542\u20131554","DOI":"10.1111\/cas.14362"},{"key":"5622_CR29","doi-asserted-by":"crossref","unstructured":"Chen K, Wang Y, Li D, Wu R, Wang J, Wei W, Zhu W, Xie W, Feng D, He Y (2024) Biological clock regulation by the PER gene family: a new perspective on tumor development. Front Cell Dev Biol 12:1332506","DOI":"10.3389\/fcell.2024.1332506"},{"key":"5622_CR30","doi-asserted-by":"crossref","unstructured":"Gong X, Tang H, Yang K (2021) PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1\/RACK1\/PI3K signaling complex. Cell Death Dis 12(3):276","DOI":"10.1038\/s41419-021-03563-5"},{"key":"5622_CR31","doi-asserted-by":"crossref","unstructured":"Lee J, Roh JL (2025) Ferroptosis in Oral Cancer: Mechanistic Insights and Clinical Prospects. Cells 14(21):1685","DOI":"10.3390\/cells14211685"},{"key":"5622_CR32","doi-asserted-by":"crossref","unstructured":"Wang F, Li C, Han F, Chen L, Zhu L (2021) BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2. Aging 13(22):24675","DOI":"10.18632\/aging.203708"},{"key":"5622_CR33","doi-asserted-by":"crossref","unstructured":"Dewhirst MW, Secomb TW (2017) Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer 17(12):738\u2013750","DOI":"10.1038\/nrc.2017.93"},{"key":"5622_CR34","doi-asserted-by":"crossref","unstructured":"Stratman AN, Davis GE (2012) Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal 18(1):68\u201380","DOI":"10.1017\/S1431927611012402"},{"key":"5622_CR35","doi-asserted-by":"crossref","unstructured":"Viallard C, Larriv\u00e9e B (2017) Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 20(4):409\u2013426","DOI":"10.1007\/s10456-017-9562-9"},{"key":"5622_CR36","doi-asserted-by":"crossref","unstructured":"Zalpoor H, Aziziyan F, Liaghat M, Bakhtiyari M, Akbari A, Nabi-Afjadi M, Forghaniesfidvajani R, Rezaei N (2022) The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. Cell Commun Signal 20(1):186","DOI":"10.1186\/s12964-022-00951-y"},{"key":"5622_CR37","doi-asserted-by":"crossref","unstructured":"Muhetarijiang M, Zhu P, Zhang H, Sun X, Wu Y, Xu Q, Justin R, Li C, Zhou D, Zhang B, Liu J (2025) A pan-cancer single-cell analysis reveals the effect of PD-1 blockades on tumor angiogenesis by inhibiting the endothelial CXCL12-CXCR4 axis. Cancer Immunol Immunother 74(11):1\u20137","DOI":"10.1007\/s00262-025-04188-9"},{"key":"5622_CR38","doi-asserted-by":"crossref","unstructured":"Liu B, Yang H, Song YS, Sorenson CM, Sheibani N (2024) Thrombospondin-1 in vascular development, vascular function, and vascular disease. Semin Cell Dev Biol 155(Pt B):32\u201344","DOI":"10.1016\/j.semcdb.2023.07.011"},{"key":"5622_CR39","doi-asserted-by":"crossref","unstructured":"Yrigoin K, Bernard KN, Casta\u00f1o MA, Cleaver O, Sumanas S, Davis GE (2024) Enhancing human capillary tube network assembly and maturation through upregulated expression of pericyte-derived TIMP-3. Front Cell Dev Biol 12:1465806","DOI":"10.3389\/fcell.2024.1465806"},{"key":"5622_CR40","doi-asserted-by":"crossref","unstructured":"Crespo M, Leiva M, Sabio G (2021) Circadian clock and liver cancer. Cancers 13(14):3631","DOI":"10.3390\/cancers13143631"},{"key":"5622_CR41","doi-asserted-by":"crossref","unstructured":"Kim DY (2024) Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide. J Liver Cancer 24(1):62\u201370","DOI":"10.17998\/jlc.2024.03.13"},{"key":"5622_CR42","doi-asserted-by":"crossref","unstructured":"Patresan J, Patel H, Chandrasekaran K, Reynolds G (2024) Current treatment paradigm and approach to advanced hepatocellular carcinoma. Cureus 16(12):e75471","DOI":"10.7759\/cureus.75471"},{"key":"5622_CR43","doi-asserted-by":"crossref","unstructured":"Qian J, Ruan MH, Wang ZJ, Dong W, Jia JY, Feng XC, Liu H (2025) Sleep disorders in hepatocellular carcinoma. World J Gastrointest Oncol 17(10):110503","DOI":"10.4251\/wjgo.v17.i10.110503"},{"key":"5622_CR44","doi-asserted-by":"crossref","unstructured":"Padilla J, Osman NM, Bissig-Choisat B, Grimm SL, Qin X, Major AM, Yang L, Lopez-Terrada D, Coarfa C, Li F, Bissig KD (2024) Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model. J Hepatol 80(2):282\u201392","DOI":"10.1016\/j.jhep.2023.10.018"},{"key":"5622_CR45","doi-asserted-by":"crossref","unstructured":"Rao X, Lin L (2022) Circadian clock as a possible control point in colorectal cancer progression. Int J Oncol 61(6):1\u20132","DOI":"10.3892\/ijo.2022.5439"},{"key":"5622_CR46","doi-asserted-by":"crossref","unstructured":"Liu Y, Hao J, Yuan G, Wei M, Bu Y, Jin T, Ma L (2021) PER1 as a tumor suppressor attenuated in the malignant phenotypes of breast cancer cells. Int J Gen Med 14:7077\u20137087","DOI":"10.2147\/IJGM.S328184"},{"key":"5622_CR47","doi-asserted-by":"crossref","unstructured":"Abou-El-Ardat K, Seifert M, Becker K, Eisenreich S, Lehmann M, Hackmann K, Rump A, Meijer G, Carvalho B, Temme A, Schackert G (2017) Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro-oncol 19(4):546\u201357","DOI":"10.1093\/neuonc\/now231"},{"key":"5622_CR48","doi-asserted-by":"crossref","unstructured":"Payne LB, Zhao H, James CC, Darden J, McGuire D, Taylor S, Smyth JW, Chappell JC (2019) The pericyte microenvironment during vascular development. Microcirculation 26(8):e12554","DOI":"10.1111\/micc.12554"},{"key":"5622_CR49","doi-asserted-by":"crossref","unstructured":"Barlow KD, Sanders AM, Soker S, Ergun S, Metheny-Barlow LJ (2013) Pericytes on the tumor vasculature: jekyll or hyde? Cancer Microenviron 6(1):1\u201317","DOI":"10.1007\/s12307-012-0102-2"},{"key":"5622_CR50","doi-asserted-by":"crossref","unstructured":"Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160(3):985\u20131000","DOI":"10.1016\/S0002-9440(10)64920-6"},{"key":"5622_CR51","doi-asserted-by":"crossref","unstructured":"Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM (2003) Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163(5):1801\u201315","DOI":"10.1016\/S0002-9440(10)63540-7"},{"key":"5622_CR52","doi-asserted-by":"crossref","unstructured":"Ciep\u0142a J, Smolarczyk R (2024) Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies. Clin Exp Med 24(1):235","DOI":"10.1007\/s10238-024-01501-1"},{"key":"5622_CR53","doi-asserted-by":"crossref","unstructured":"Tang N, Wang L, Esko J, Giordano FJ, Huang Y, Gerber HP, Ferrara N, Johnson RS (2004) Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6(5):485\u2013495","DOI":"10.1016\/j.ccr.2004.09.026"},{"key":"5622_CR54","doi-asserted-by":"crossref","unstructured":"Guo L, Cen H, Weng J, He Y, Guo X, He D, Liu K, Duan S, Yang J, Zhang X, Qin Z (2023) PER2 integrates circadian disruption and pituitary tumorigenesis. Theranostics 13(8):2657","DOI":"10.7150\/thno.82995"},{"key":"5622_CR55","doi-asserted-by":"crossref","unstructured":"Li Y, Li B, Yang K, Zhu L, Tang H, Huang Y, Deng J, Duan J (2025) PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1\u03b1 degradation. Transl Oncol 52:102258","DOI":"10.1016\/j.tranon.2024.102258"},{"key":"5622_CR56","doi-asserted-by":"crossref","unstructured":"Yang Y, Tang H, Zheng J, Yang K (2022) The PER1\/HIF-1alpha negative feedback loop promotes ferroptosis and inhibits tumor progression in oral squamous cell carcinoma. Transl Oncol 18:101360","DOI":"10.1016\/j.tranon.2022.101360"},{"key":"5622_CR57","doi-asserted-by":"crossref","unstructured":"Chen ZX, Mu MY, Yang G, Qi H, Fu XB, Wang GS, Jiang WW, Huang BJ, Gao F (2024) Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation. Cell Death Dis 15(10):734","DOI":"10.1038\/s41419-024-07089-4"},{"key":"5622_CR58","doi-asserted-by":"crossref","unstructured":"Zeng Z, Lu Q, Liu Y, Zhao J, Zhang Q, Hu L, Shi Z, Tu Y, Xiao Z, Xu Q, Huang D (2021) Effect of the hypoxia inducible factor on sorafenib resistance of hepatocellular carcinoma. Front Oncol 11:641522","DOI":"10.3389\/fonc.2021.641522"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05622-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05622-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05622-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:15:11Z","timestamp":1787908511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05622-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5622"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05622-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Air Force Medical University Ethics Committee and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol and informed consent form were reviewed and approved by the Xiangya Hospital (No.202103439).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}